Sirfbio

Hyderabad, India Founded: 2014 • Age: 12 yrs
Automated nucleic acid extraction devices are developed for diagnostic applications.

About Sirfbio

Sirfbio is a Healthcare company based in Hyderabad (India) founded in 2014 by Shesheer Kumar. Automated nucleic acid extraction devices are developed for diagnostic applications. Its Indian entity Sirf Bio Private Limited reported revenue of β‚Ή23.7 Lakh. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Genomics.

Company details

Sirfbio was founded in 2014 in Hyderabad, India, within the biotechnology sector. Automated nucleic acid extraction devices are developed by the company, alongside an integrated real-time PCR system that handles isolation, amplification, and detection on one platform. DNA extraction processes are automated to produce reagents targeting infections such as malaria, tuberculosis, and leishmania. These solutions are designed for deployment in rural dispensaries across regions with limited infrastructure.

Key Metrics
  • Annual Revenue
    ₹23.7 Lakh

    FY 2025 · +235% YoY

  • Net Loss
    -₹3.2 Lakh

    FY 2025 · -14% margin

  • EBITDA
    -₹1.6 Lakh

    FY 2025 · -7% margin

Board of directors of Sirf Bio Private Limited (Sirfbio)

Sirf Bio Private Limited is the primary company behind Sirfbio. The board of Sirf Bio Private Limited currently have 2 directors; the longest-serving is Suresh Gajanan Patwardhan, appointed in 2014. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Suresh Gajanan Patwardhan
DIN 01890118
Director18 Dec 201411 yrs 10 moSirf Bio Private Limited
Shesheer Kumar Munpally
DIN 00554826
Director07 Aug 20179 yrs 2 moSirf Bio Private Limited

People of Sirfbio

1 people are tracked at Sirfbio (1 in leadership).

NameRoleGroup
FounderLeadership
Premium access

Complete people profiles for Sirfbio

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Sirfbio

Figures of Sirf Bio Private Limited, the primary company behind Sirfbio, for FY 2025. Revenue was ₹23.7 Lakh (+235% year on year). Net loss was -₹3.2 Lakh (-14% margin). EBITDA was -₹1.6 Lakh (-7% margin). Revenue has grown at a compounded annual rate of -23% over three years and +136% over five years.

  • ₹23.7 LakhRevenue · FY 2025 · +235% YoY
  • -₹3.2 LakhNet loss · -14% margin
  • -₹1.6 LakhEBITDA · -7% margin
  • ₹1 LakhPaid-up capital
  • -23%Revenue CAGR, 3 years
  • +136%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Sirf Bio Private Limited are on its company page.

Premium access

Detailed financial statements for Sirfbio

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Sirfbio

Sirfbio was founded in 2014.

Sirfbio is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

The primary company behind Sirfbio, Sirf Bio Private Limited, reported revenue of β‚Ή23.7 Lakh for FY 2025, up 235% year on year.

Sirfbio was founded in 2014 in Hyderabad, India, within the biotechnology sector. Automated nucleic acid extraction devices are developed by the company, alongside an integrated real-time PCR system that handles isolation, amplification, and detection on one platform. DNA extraction processes are automated to produce reagents targeting infections such as malaria, tuberculosis, and leishmania. These solutions are designed for deployment in rural dispensaries across regions with limited infrastructure.

Sirfbio operates through Sirf Bio Private Limited.

The legal entities of Sirfbio currently have 2 directors, including Suresh Gajanan Patwardhan, Shesheer Kumar Munpally.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available